Naresh Chouhan

Naresh Chouhan

Naresh started his career in GSK’s Corporate Development team conducting Merger modelling, Biotech screens and worked on strategic transactions. He moved to JPMorgan on the sell-side in 2006 to cover Pan-Euro Large cap Pharma. Having spent time at HSBC and 6 years as the head of Healthcare research at Liberum, he joined New Street Research as a Partner and founded the Healthcare franchise in 2016 (now rebranded as Intron Health). Naresh has worked on numerous Capital market transactions and been the lead analyst on 2 Healthcare IPO’s.

Dominic Rose

Dominic Rose

Dominic has an MA degree in Natural Sciences from Cambridge and six years’ experience in the market having joined the M&G Investment Graduate Scheme in 2012. He gained experience across the investment business including equity research, leveraged finance and fund management. In 2015, he joined Liberum as an equity pharmaceuticals analyst and moved to New Street in 2016 with Naresh Chouhan. Dominic is also a CFA charterholder.

Gengyu Li

Dr Gengyu Li

Recently joined the Healthcare team as an Associate Analyst. Previously, he worked as Pharmaceutical Analyst at GlobalData in London covering neurology and ophthalmology indications. Before that, Gengyu was an Analyst in Tax Consulting at Deloitte. Gengyu received his D.Phil in Pharmacology from the University of Oxford and BA in Natural Sciences from the University of Cambridge.

Lal Kandiah

Lal Kandiah

Lal has trained as CIMA accountant and has a degree in computer systems design. He previously spent 12 years working within the voluntary sector and 3 years in the hospitality sector, in both cases as head of accounts. He joined the Healthcare team in 2017 to help with the teams’ modelling and analysis efforts.

Larry Stevens

Lawrence Stevens

Lawrence Stevens (Larry) is the most experienced American selling European equity research to US institutional clients, having started in 1985, with recent jobs at Lehman and HSBC. He graduated in 1974 with a BSE from Princeton University in Quantitative Analysis and has done the course work for an MBA from NYU, minoring in PhD-level macroeconomics. In addition, to selling our Healthcare research, Larry also writes macroeconomic/investment commentary for his clients.

Maria Van Tonder

Maria Van Tonder

Maria joined New Street Research LLP in 2008 with the Pharmaceutical analyst team before taking on the role of Finance Director in 2011. Prior to joining NSR she worked in the Equity Research operations team at HSBC, having previously held roles in private equity M&A and equity research at UBS.